Vericel earnings were $7.1M for the trailing 12 months ending Jun 30, 2025, with 1,300% growth year over year. The latest VCEL earnings report on Jun 30, 2025 announced Q2 2025 earnings of -$553.0k, down 95.1% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, VCEL reported annual earnings of $10.4M, with -425.6% growth.
VCEL past earnings growth
How has VCEL's earnings growth performed historically?
On VCEL's earnings call on Invalid Date, Vericel (NASDAQ: VCEL) reported Q2 2025 earnings per share (EPS) of -$0.01, up 90% year over year. Total VCEL earnings for the quarter were -$553.00 thousand. In the same quarter last year, Vericel's earnings per share (EPS) was -$0.10.
As of the last Vericel earnings report, Vericel is currently profitable. Vericel's net profit (also called net income) for the twelve months ending Jun 30, 2025 was $7.11 million, a 800.76% increase year over year.
What was VCEL's earnings growth in the past year?
As of Vericel's earnings date in Invalid Date, Vericel's earnings has grown 1,300% year over year. This is 1,268.34 percentage points higher than the US Biotechnology industry earnings growth rate of 31.66%. VCEL earnings in the past year totalled $7.11 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.